...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset
【24h】

A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset

机译:放射敏感性基因签名和PD-L1状态预测癌症基因组地图集(TCGA)数据集中侵入性乳腺癌患者的临床结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: We investigated the link between the radiosensitivity gene signature and programmed cell death ligand 1 (PD-L1) status and clinical outcome in order to identify a group of patients that would possibly receive clinical benefit of radiotherapy (RT) combined with anti-PD1/PD-L1 therapy.
机译:背景和目的:我们研究了放射敏感性基因签名和编程细胞死亡配体1(PD-L1)状态和临床结果之间的联系,以鉴定一组可能接受放疗(RT)的临床益处(RT)与抗的临床效益 -PD1 / PD-L1疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号